TAK · ISSUER CIK 1395064
TAKEDA PHARMACEUTICAL CO LTD
Between Aug 1, 2026 and Oct 29, 2026, 13 TAKEDA PHARMACEUTICAL CO LTD insiders reported $0.00 of open-market purchases and $13.1M of sales on SEC Form 4.
↗13 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 19 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$13.1MInsider selling
−$13.1MNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202621:12 | Sep 14, 2026 | TAK | Chief Transformation Officer | S · Sell | $18.54 | −34,535 | 191,522 | -15% | −$640K | ||
| Sep 3, 202621:49 | Sep 2, 2026 | TAK | President, R&D, Director | S · Sell10b5-1 | $18.49 | −116,191 | 145,465 | -44% | −$2.1M | ||
| Aug 21, 202616:30 | Aug 19, 2026 | TAK | President, R&D, Director | S · Sell10b5-1 | $18.49 | −19,651 | 261,656 | -7% | −$363K | ||
| Aug 19, 202616:15 | Aug 18, 2026 | TAK | Chief Human Resources Officer | S · Sell | $18.11 | −12,980 | 40,049 | -24% | −$235K | ||
| Aug 12, 202621:54 | Aug 10, 2026 | TAK | Chief Medical Officer | S · Sell | $17.10 | −14,006 | 116,177 | -11% | −$240K | ||
| Aug 12, 202621:53 | Aug 10, 2026 | TAK | President, PDT BU | S · Sell | $17.10 | −7,277 | 102,588 | -7% | −$124K | ||
| Aug 12, 202621:53 | Aug 10, 2026 | TAK | President, U.S. Business Unit | S · Sell | $17.10 | −16,901 | 182,507 | -8% | −$289K | ||
| Aug 12, 202621:51 | Aug 10, 2026 | TAK | Chief Transformation Officer | S · Sell | $17.10 | −47,586 | 226,057 | -17% | −$814K | ||
| Aug 12, 202621:50 | Aug 10, 2026 | TAK | President, R&D, Director | S · Sell | $17.10 | −165,393 | 766,569 | -18% | −$2.8M | ||
| Aug 12, 202621:46 | Aug 10, 2026 | TAK | Head, Strat. & Port. Dev | S · Sell | $17.10 | −22,957 | 176,977 | -11% | −$393K | ||
| Aug 12, 202621:45 | Aug 10, 2026 | TAK | President, OBU | S · Sell | $17.10 | −50,012 | 252,010 | -17% | −$855K | ||
| Aug 12, 202621:42 | Aug 10, 2026 | TAK | Pres., Global Supply & Quality | S · Sell | $17.10 | −3,978 | 63,333 | -6% | −$68K | ||
| Aug 12, 202621:39 | Aug 10, 2026 | TAK | Chief Data & Tech. Officer | S · Sell | $17.10 | −25,088 | 171,654 | -13% | −$429K | ||
| Aug 12, 202621:28 | Aug 10, 2026 | TAK | Chief Human Resources Officer | S · Sell | $17.10 | −6,774 | 53,029 | -11% | −$116K | ||
| Aug 12, 202621:27 | Aug 10, 2026 | TAK | President and CEO, Director | S · Sell | $17.10 | −89,090 | 391,489 | -19% | −$1.5M | ||
| Aug 12, 202621:25 | Aug 10, 2026 | TAK | President, IBU | S · Sell | $17.10 | −31,083 | 315,838 | -9% | −$532K | ||
| Aug 12, 202621:23 | Aug 10, 2026 | TAK | Global General Counsel | S · Sell | $17.10 | −30,868 | 204,298 | -13% | −$528K | ||
| Aug 12, 202616:10 | Aug 11, 2026 | TAK | Pres., Global Supply & Quality | S · Sell | $17.55 | −20,363 | 67,311 | -23% | −$357K | ||
| Aug 12, 202616:10 | Aug 10, 2026 | TAK | Chief Human Resources Officer | S · Sell | $17.51 | −34,603 | 59,803 | -37% | −$606K |